Mersana Therapeutics
MRSN
#8916
Rank
NZ$0.24 B
Marketcap
NZ$48.45
Share price
0.29%
Change (1 day)
-54.66%
Change (1 year)

Earnings for Mersana Therapeutics (MRSN)

Earnings in 2025 (TTM): -NZ$0.13 Billion

According to Mersana Therapeutics's latest financial reports the company's current earnings are NZ$34.76 Million. In 2024 the company made an earning of -NZ$0.12 Billion, an increase over its 2023 earnings that were of -NZ$0.3 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Mersana Therapeutics from 2016 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.13 Billion5.69%
2024 -NZ$0.12 Billion-59.94%
2023 -NZ$0.3 Billion-15.94%
2022 -NZ$0.36 Billion20.08%
2021 -NZ$0.3 Billion93.16%
2020 -NZ$0.16 Billion212.12%
2019 -NZ$48.48 Million-56.1%
2018 -NZ$0.12 Billion66.02%
2017 -NZ$66.52 Million182.53%
2016 -NZ$23.55 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.26 Billion 101.07%๐Ÿ‡บ๐Ÿ‡ธ USA